These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2008146)

  • 21. [Insulin therapy with pens and pumps].
    Schwedes U
    Med Klin (Munich); 1996 Feb; 91 Suppl 1():16. PubMed ID: 8839106
    [No Abstract]   [Full Text] [Related]  

  • 22. [Metabolic control using a subcutaneous insulin infusion pump: effects 2 years after treatment].
    Goicolea Opacua I; Martínez Castillo A; Santamaría Pelarda E; Sola Sarabia C; Vázquez García JA
    Rev Clin Esp; 1988 Mar; 182(4):200-2. PubMed ID: 3045905
    [No Abstract]   [Full Text] [Related]  

  • 23. Severe autonomic neuropathy treated with subcutaneous insulin infusion.
    Prendergast JJ; Aubry W
    Diabetes Care; 1996 Jan; 19(1):90. PubMed ID: 8720543
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of multiple insulin injections with a pen injector on metabolic control and general well-being in insulin-dependent diabetes mellitus.
    Gall MA; Mathiesen ER; Skøtt P; Musaeus L; Damm S; Beck-Nielsen H; Parving HH
    Diabetes Res; 1989 Jun; 11(2):97-101. PubMed ID: 2515935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Insulin pump versus insulin pen].
    Schlimpert V
    MMW Fortschr Med; 2014 Oct; 156(17):26. PubMed ID: 25417459
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of the pen delivery system for intensive insulin therapy in college-age students with type I diabetes.
    Chase HP; Garg SK; Hoops SL; Harris S; Wilcox W
    J Adolesc Health; 1991 Jul; 12(5):373-6. PubMed ID: 1751505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The suboptimal roadmap to the intensive therapy target.
    Davidson P; Hebblewhite H; Steed RD; Bode B
    Diabetes Technol Ther; 2004 Feb; 6(1):17-9. PubMed ID: 15000765
    [No Abstract]   [Full Text] [Related]  

  • 28. Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study.
    Abell SK; Suen M; Pease A; Boyle JA; Soldatos G; Regan J; Wallace EM; Teede HJ
    Diabetes Technol Ther; 2017 May; 19(5):280-287. PubMed ID: 28282241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.
    DeVries JH; Snoek FJ; Kostense PJ; Masurel N; Heine RJ;
    Diabetes Care; 2002 Nov; 25(11):2074-80. PubMed ID: 12401759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment options for insulin-dependent diabetes mellitus: a comparison of the artificial endocrine pancreas, continuous subcutaneous insulin infusion, and multiple daily insulin injections.
    Rizza RA
    Mayo Clin Proc; 1986 Oct; 61(10):796-805. PubMed ID: 3091967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tailoring intensified insulin therapy in children.
    Danne T
    Pediatr Diabetes; 2009 Aug; 10(5):295-7. PubMed ID: 19682282
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of insulin pen injection frequency on quality of life.
    Andersson PO; Wikby A; Hörnquist JO
    Diabetes Care; 1990 Nov; 13(11):1135-6. PubMed ID: 2261832
    [No Abstract]   [Full Text] [Related]  

  • 33. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c: response to Retnakaran et al.
    Blumer I
    Diabetes Care; 2005 Mar; 28(3):763; author reply 763-4. PubMed ID: 15735237
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of Automation/Technology in Day-to-Day Diabetes Care.
    Dadlani V; Kudva YC
    Diabetes Technol Ther; 2016 May; 18(5):273-5. PubMed ID: 27028696
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparing continuous subcutaneous insulin infusion and multiple daily injections in children with Type 1 diabetes in Sweden from 2011 to 2016-A longitudinal study from the Swedish National Quality Register (SWEDIABKIDS).
    Fureman AL; Lilja M; Lind T; Särnblad S; Bladh M; Samuelsson U
    Pediatr Diabetes; 2021 Aug; 22(5):766-775. PubMed ID: 33929074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.
    Bergenstal RM; Tamborlane WV; Ahmann A; Buse JB; Dailey G; Davis SN; Joyce C; Peoples T; Perkins BA; Welsh JB; Willi SM; Wood MA;
    N Engl J Med; 2010 Jul; 363(4):311-20. PubMed ID: 20587585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis.
    Benkhadra K; Alahdab F; Tamhane SU; McCoy RG; Prokop LJ; Murad MH
    Endocrine; 2017 Jan; 55(1):77-84. PubMed ID: 27477293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bariatric surgery results in patients with type 1 diabetes mellitus on continuous subcutaneous insulin infusion therapy.
    Moreno-Fernandez J; Chico A;
    Endocrinol Nutr; 2016 Dec; 63(10):571-572. PubMed ID: 27765489
    [No Abstract]   [Full Text] [Related]  

  • 39. Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients.
    Selam JL; Raccah D; Jean-Didier N; Lozano JL; Waxman K; Charles MA
    Diabetes Care; 1992 Jan; 15(1):53-8. PubMed ID: 1737542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment and glycemic control of 1200 diabetic patients enrolled at the National Institute of Disease-Disability Insurance diabetes convention].
    Buysschaert M; Maes M; Hermans MP
    Acta Clin Belg; 1997; 52(4):211-8. PubMed ID: 9412121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.